News | December 20, 2023
Venus Remedies' R3SET forays into wellness
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
The product will be manufactured at Lupin's Pithampur facility in India
Lupin Vilfuro-G is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
The Main campaign started from October 2
Subscribe To Our Newsletter & Stay Updated
